---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-26-000038"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:30:46.070705+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kevin Sayer returns as DexCom Executive Chairman on Mar 2 with new comp terms

## Summary
- Kevin Sayer returns from temporary leave effective March 2, 2026, resuming Executive Chairman role.
- New letter agreement provides annual base salary of $610,000; no annual bonus.
- RSU grant of $2,350,000 to be awarded on March 8, 2026, vesting in full on March 8, 2027.
- Former equity awards continue to vest; Sayer no longer eligible for Company's severance plan.
- Mark Foletta resumes duties as Lead Independent Director upon Sayer's return.

## SEC filing metadata
- accession: 0001093557-26-000038
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000038/0001093557-26-000038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000038/dxcm-20260227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-26-000038
- JSON: https://secwatch.observer/filing/0001093557-26-000038.json
- Plain text: https://secwatch.observer/filing/0001093557-26-000038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.